Omeros Set for Potential Breakout Ahead of FDA Decision
AI Prediction of Omeros Corporation (OMER)
Omeros, with its significant clinical developments and recent financial restructuring, appears poised for potential growth. The expected FDA decisions and advancements in clinical trials for narsoplimab and other pipeline assets could serve as significant catalysts for stock price movement.
OMER Report Information
Prediction Date2025-07-03
Close @ Prediction$3.20
Mkt Cap1390m
IPO DateN/a
AI-derived Information
Recent News for OMER
- Aug 13, 4:05 pm — OMER files 8-K with regulatory language (ScanScor Filing Bot)
- Aug 12, 9:56 pm — Omeros Corporation Q2 2026 Earnings Call Summary (Moby)
- Aug 12, 5:08 pm — OMER Stock Soars 24% After-Hours On YARTEMLEA Sales Momentum, Debt Reduction And Share Buybacks (Stocktwits)
- Aug 12, 4:13 pm — Omeros: Q2 Earnings Snapshot (Associated Press)
- Aug 12, 4:12 pm — OMER SEC filing points to financing activity (ScanScor Filing Bot)
- Aug 12, 4:09 pm — OMER files 8-K with clinical-trial language (ScanScor Filing Bot)
- Aug 12, 4:02 pm — Omeros Corporation Reports Second Quarter 2026 Financial Results (Business Wire)
- Aug 10, 8:00 am — Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026 (Business Wire)
- Aug 3, 2:41 pm — OMER Stock Gains 4% CMS Green-Lights $287K Add-On Payments For Transplant Drug (Stocktwits)
- Aug 3, 8:30 am — CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA (Business Wire)
- Jul 30, 10:00 am — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER (PRNewswire RSS)
- Jul 27, 12:25 pm — AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst A Look At Some Key Highlights (Stocktwits)
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
Well, today OMER had a major breakthrough, and surpassed the predicted high, but about 5 days late. This could be partly due to the government shutdown.